Jussi Hepojoki

InstitutionUniversity of Zürich
AddressZürich
Switzerland
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 3 publications in May 2021
    All Publications
    Bar chart showing 47 publications over 13 distinct years, with a maximum of 7 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Jalkanen P, Kolehmainen P, Häkkinen HK, Huttunen M, Tähtinen PA, Lundberg R, Maljanen S, Reinholm A, Tauriainen S, Pakkanen SH, Levonen I, Nousiainen A, Miller T, Välimaa H, Ivaska L, Pasternack A, Naves R, Ritvos O, Österlund P, Kuivanen S, Smura T, Hepojoki J, Vapalahti O, Lempainen J, Kakkola L, Kantele A, Julkunen I. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants. Nat Commun. 2021 06 28; 12(1):3991. PMID: 34183681.
      Citations: 44     Fields:    Translation:HumansPHPublic Health
    2. Salmi H, Heinonen S, Hästbacka J, Lääperi M, Rautiainen P, Miettinen PJ, Vapalahti O, Hepojoki J, Knip M. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic. Arch Dis Child. 2022 02; 107(2):180-185. PMID: 34045208.
      Citations: 4     Fields:    
    3. Virtanen J, Uusitalo R, Korhonen EM, Aaltonen K, Smura T, Kuivanen S, Pakkanen SH, Mero S, Patjas A, Riekkinen M, Kantele A, Nurmi V, Hedman K, Hepojoki J, Sironen T, Huhtamo E, Vapalahti O. Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays. Viruses. 2021 05 26; 13(6). PMID: 34073577.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    4. Rusanen J, Kareinen L, Szirovicza L, Ugurlu H, Levanov L, Jääskeläinen A, Ahava M, Kurkela S, Saksela K, Hedman K, Vapalahti O, Hepojoki J. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept. mBio. 2021 05 18; 12(3). PMID: 34006662.
      Citations: 5     Fields:    Translation:HumansCells
    5. Jääskeläinen AE, Ahava MJ, Jokela P, Szirovicza L, Pohjala S, Vapalahti O, Lappalainen M, Hepojoki J, Kurkela S. Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection. J Clin Virol. 2021 04; 137:104785. PMID: 33711694.
      Citations: 11     Fields:    Translation:Humans
    6. Rusanen J, Kareinen L, Levanov L, Mero S, Pakkanen SH, Kantele A, Amanat F, Krammer F, Hedman K, Vapalahti O, Hepojoki J. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2. Viruses. 2021 Jan 20; 13(2). PMID: 33498157.
      Citations: 3     Fields:    Translation:Humans
    7. Citations: 413     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    8. Dervas E, Hepojoki J, Smura T, Prähauser B, Windbichler K, Blümich S, Ramis A, Hetzel U, Kipar A. Serpentoviruses: More than Respiratory Pathogens. J Virol. 2020 08 31; 94(18). PMID: 32641481.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    9. Rodriguez L, Pekkarinen PT, Lakshmikanth T, Tan Z, Consiglio CR, Pou C, Chen Y, Mugabo CH, Nguyen NA, Nowlan K, Strandin T, Levanov L, Mikes J, Wang J, Kantele A, Hepojoki J, Vapalahti O, Heinonen S, Kekäläinen E, Brodin P. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19. Cell Rep Med. 2020 08 25; 1(5):100078. PMID: 32838342.
      Citations: 55     
    10. Citations: 616     Fields:    Translation:HumansCellsPHPublic Health
    11. Haveri A, Smura T, Kuivanen S, Österlund P, Hepojoki J, Ikonen N, Pitkäpaasi M, Blomqvist S, Rönkkö E, Kantele A, Strandin T, Kallio-Kokko H, Mannonen L, Lappalainen M, Broas M, Jiang M, Siira L, Salminen M, Puumalainen T, Sane J, Melin M, Vapalahti O, Savolainen-Kopra C. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020. Euro Surveill. 2020 03; 25(11). PMID: 32209163.
      Citations: 102     Fields:    Translation:HumansCellsPHPublic Health
    Hepojoki's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (160)
    Explore
    _
    Co-Authors (150)
    Explore
    _
    Similar People (60)
    Explore
    _